[HTML][HTML] Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma
Y Haruyama, H Kataoka - World journal of gastroenterology, 2016 - ncbi.nlm.nih.gov
… -3 expression is a significant prognostic factor that predicts poor outcome of patients … target
for the development of novel therapies for HCC, and preclinical and clinical trials targeting …
for the development of novel therapies for HCC, and preclinical and clinical trials targeting …
Prognostic factors in advanced non-small cell lung cancer patients treated with immunotherapy
D Rocco, L Della Gravara, A Ragone, L Sapio… - Cancers, 2023 - mdpi.com
… Ratio (NLR) has been associated with a poor prognostic value in NSCLC patients receiving
chemotherapy, targeted therapy, and immunotherapy. In fact, NSCLC patients with a high …
chemotherapy, targeted therapy, and immunotherapy. In fact, NSCLC patients with a high …
Predictive Factors of Immunotherapy in Gastric Cancer: A 2024 Update
V Bintintan, C Burz, I Pintea, A Muntean, D Deleanu… - Diagnostics, 2024 - mdpi.com
… in GC tissues, ACVR1 could be a promising target for GC immunotherapy [49]. Fc gamma
receptor … -type macrophages and relevant prognostic factors for predicting immunotherapy and …
receptor … -type macrophages and relevant prognostic factors for predicting immunotherapy and …
Targeted therapies to improve tumor immunotherapy
… approaches with immunotherapy. In this article, we postulate that targeted agents against key
… Prognostic factors related to clinical response in patients with metastatic melanoma treated …
… Prognostic factors related to clinical response in patients with metastatic melanoma treated …
Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer
Y Zhao, S Jia, K Zhang, L Zhang - Frontiers in oncology, 2023 - frontiersin.org
… biomarkers for lung cancer and predict the effectiveness of targeted immunotherapy. …
However, a prognostic factor cannot provide information on a specific therapy’s advantages. …
However, a prognostic factor cannot provide information on a specific therapy’s advantages. …
Inflammatory factors are associated with prognosis of non-small cell lung cancer patients receiving immunotherapy: a meta-analysis
W Tong, H Xu, J Tang, N Zhao, D Zhou, C Chen… - Scientific Reports, 2024 - nature.com
… -based prognostic factors, such as C-reactive protein (CRP), on the prognosis of NSCLC …
patients, evaluating factors such as CRP, the modified Glasgow Prognostic Score (mGPS), …
patients, evaluating factors such as CRP, the modified Glasgow Prognostic Score (mGPS), …
Prognostic factors in renal cell carcinoma
A Volpe, JJ Patard - World journal of urology, 2010 - Springer
… was considered an important prognostic factor in the era of immunotherapy [81]. It … prognostic
factor in mRCC. This has been clearly established both in the immunotherapy and targeted …
factor in mRCC. This has been clearly established both in the immunotherapy and targeted …
Pyroptosis-related genes prognostic model for predicting targeted therapy and immunotherapy response in soft tissue sarcoma
M Liu, Q Li, Y Liang - Frontiers in Pharmacology, 2023 - frontiersin.org
… Afterward, it was determined whether PRGs-risk scores may be independent prognostic
factors through univariate and multivariate cox regression analyses. The high PRGs-risk score …
factors through univariate and multivariate cox regression analyses. The high PRGs-risk score …
Predicting response of immunotherapy and targeted therapy and prognosis characteristics for renal clear cell carcinoma based on m1A methylation regulators
L Li, H Tan, J Zhou, F Hu - Scientific Reports, 2023 - nature.com
… Prognostic signature of the four related regulators in the training set of … prognostic factors
for KIRC OS. (A,B) The training set of forrest plot of the independent prognostic factors in KIRC. (…
for KIRC OS. (A,B) The training set of forrest plot of the independent prognostic factors in KIRC. (…
PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma
MC Gelmi, G Gezgin… - … & Visual Science, 2023 - iovs.arvojournals.org
… Conclusions: We confirm that PRAME is associated with poor prognosis in UM and has a
strong connection with extra copies of 8q. We show that PRAME-specific immunotherapy in an …
strong connection with extra copies of 8q. We show that PRAME-specific immunotherapy in an …
相关搜索
- renal cell carcinoma prognostic factors
- prognostic factor target for cancer immunotherapy
- significant prognostic factors
- immunotherapeutic target glypican 3
- cell lung cancer patients prognostic factors
- tumor immunotherapy targeted therapies
- other associated factors prognostic indicators
- genes prognostic model immunotherapy response
- potential target for immunotherapy
- immunotherapy in gastric cancer predictive factors
- prognostic value inflammatory factors
- prognostic factor in uveal melanoma
- prognostic factor prame expression
- immunotherapeutic target hepatocellular carcinoma
- predictive models prognostic factors
- retrospective analysis prognostic factors